Donepezil's effects remain uncertain.
Royall
Donald R
DR
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000077265:Donepezil; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000627:therapeutic use*; D007326:Institutionalization; D008962:Models, Theoretical; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009735:Nursing Homes; D010349:Patient Compliance; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D010919:Placebos; D000077265:Donepezil